Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England

The emergence of the COVID-19 vaccination has been critical in changing the course of the COVID-19 pandemic. To ensure protection remains high in vulnerable groups booster vaccinations in the UK have been targeted based on age and clinical vulnerabilities. We undertook a national retrospective cohor...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Ward, IL, Robertson, C, Agrawal, U, Patterson, L, Bradley, DT, Shi, T, de Lusignan, S, Hobbs, FDR, Sheikh, A, Nafilyan, V
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Springer Nature 2024

Míreanna comhchosúla

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
de réir: Isobel L. Ward, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
de réir: Bedston, S, et al.
Foilsithe / Cruthaithe: (2023)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
de réir: Gu, X, et al.
Foilsithe / Cruthaithe: (2024)

Variation in COVID-19 booster uptake in England: An ecological study.
de réir: Greg Dropkin
Foilsithe / Cruthaithe: (2022-01-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context
de réir: Stuart Bedston, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
de réir: Piotr Rzymski, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
de réir: Agrawal, U, et al.
Foilsithe / Cruthaithe: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
de réir: Rahul Shekhar, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
de réir: Guido Bendezu-Quispe, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Excess mortality from COVID-19 in an English sentinel network population
de réir: Joy, M, et al.
Foilsithe / Cruthaithe: (2020)

Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine roll-out.
de réir: Matt Bosworth, et al.
Foilsithe / Cruthaithe: (2022-08-01)

The Correlates & Public Health Consequences of Prospective Vaccine Hesitancy among Individuals Who Received COVID-19 Vaccine Boosters in the U.S.
de réir: Matt Motta
Foilsithe / Cruthaithe: (2022-10-01)

Waning of first and second dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
de réir: Kerr, S, et al.
Foilsithe / Cruthaithe: (2022)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
de réir: Xinchun Gu, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Predicting the intention to receive the COVID-19 booster vaccine based on the health belief model
de réir: Milja Ventonen, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy
de réir: Lucio Folcarelli, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review
de réir: Yam B. Limbu, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
de réir: Li Ping Wong, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Covid-19 booster shot advisable
de réir: The Star
Foilsithe / Cruthaithe: (2021)

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study
de réir: Tsang, RSM, et al.
Foilsithe / Cruthaithe: (2023)

Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
de réir: Vahé Nafilyan, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Longitudinal changes in proportionate mortality due to COVID-19 by occupation in England and Wales
de réir: Mark Cherrie, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Factors Influencing the Healthcare Workers’ Willingness to Receive the COVID-19 Booster Dose in Tuscany (Italy)
de réir: Giovanni Guarducci, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia
de réir: Kirsten Barnes, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy
de réir: Giorgia Della Polla, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Factors Associated With Marshallese and Hispanic Adults’ Willingness to Receive a COVID-19 Booster Dose
de réir: Rachel S. Purvis, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Lessons from the English primary care sentinel network's response to the COVID-19 pandemic
de réir: de Lusignan, S, et al.
Foilsithe / Cruthaithe: (2023)

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study
de réir: Tsang, RS, et al.
Foilsithe / Cruthaithe: (2023)

Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
de réir: Bermingham, C, et al.
Foilsithe / Cruthaithe: (2022)

Evaluation of COVID-19 Booster Vaccine Effectiveness
de réir: Bingqian Qu, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Booster Dose of COVID 19 and Ethical Issues
de réir: Adeela Shahid
Foilsithe / Cruthaithe: (2021-12-01)

Booster Vaccination Strategies for “Living With COVID-19”
de réir: Jung Eun Kim, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
de réir: Freja Cordelia Møller Kirsebom, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
de réir: Chung-Jong Kim, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel
de réir: Nicholas M. Mohr, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Healthcare workers’ willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo
de réir: Bertin Mindje Kolomba, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine
de réir: Piotr Rzymski, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
de réir: Walid Al-Qerem, et al.
Foilsithe / Cruthaithe: (2022-03-01)

The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
de réir: Liling Chen, et al.
Foilsithe / Cruthaithe: (2023-01-01)

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: a national prospective cohort study
de réir: Bedston, S, et al.
Foilsithe / Cruthaithe: (2023)